US EditionModerna to roll out first made-in-Canada COVID-19 vaccines this fall
Moderna's Spikevax vaccine, targeting the SARS-CoV-2 LP.8.1 variant, is now produced in Canada, enhancing national health security and supply chain resilience for upcoming respiratory seasons.
- Moderna began delivering the first made-in-Canada COVID-19 vaccines targeting the SARS-CoV-2 LP.8.1 variant in August 2025 from its Laval, Quebec, and Cambridge, Ontario, facilities.
- This milestone follows the Canadian government’s cancellation of a contract with Novavax, which failed to get regulatory approval to produce vaccines at the Montreal facility built with federal funds.
- Moderna’s Laval site, its first manufacturing location outside the United States, is capable of annually manufacturing as many as 100 million doses of mRNA vaccines and will support production for COVID-19 as well as respiratory syncytial virus inoculations.
- Health Canada approved Moderna’s Spikevax vaccine on August 21, 2025, and Canada’s National Advisory Committee on Immunization recommends it for all Canadians aged six months and older, prioritizing higher-risk groups.
- This achievement enhances Canada’s ability to produce vaccines domestically, boosts public health resilience, and contributes to the local economy by establishing advanced vaccine manufacturing capabilities.
16 Articles
16 Articles
natlawreview.com
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
CAMBRIDGE, MA / ACCESS Newswire / September 19, 2025 / Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinc
Feds, Moderna Announce First Batch of Canadian mRNA Vaccines
Moderna has produced the first Canadian-made doses of its mRNA vaccines in its new facility in Laval, Que., the company’s CEO says. “We want to bring this mRNA technology to help as many people as we can,” Moderna CEO Stéphane Bancel said at a Sept. 19 press conference in Laval. “COVID is just the beginning. We have so many more exciting products coming in infectious disease, but also cancer, in rare genetic disease, and soon, I believe, in auto…
The Moderna plant in Laval delivered its first doses of mRNA vaccines against VOCID-19. Ottawa hopes that the plant will allow the country's medical autonomy.
Federal Government Announces That Moderna Has Started Production At Its Biomanufacturing Facility - Canadian Manufacturing
LAVAL — On Sep. 19, Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, and Marjorie Michel, Minister of Health, along with Stéphane Bancel, Chief Executive Officer of Moderna, announced that Moderna has achieved a milestone, producing its first doses of the COVID-19 vaccine at its new mRNA vaccine biomanufacturing facility in Laval, Quebec. This milestone represents a step forward in t…
Moderna Produces Its First Canadian mRNA COVID-19 Vaccines In Its New State-Of-The-Art Quebec Facility
Canadian Minister of Indusry and Minister responsible for Economic Development Melanie Joly “Today’s (September 19th, 2025) milestone of the production of the first made-in-Canada doses of Moderna’s COVID-19 vaccine represents a major achievement for Canada’s biomanufacturing and life sciences sector. Our government is building a resilient, forward-looking economy that positions Canada as a global leader in scientific research and innovation.” …
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
